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Update
Cardiac transplantation has been the treatment of
choice for patients with terminal cardiac insufficiency, incre-
asing survival time by more than 80% in the first year 1 and
by more than 50% over ten years 2. Following cardiac trans-
plantation, the quality of life improves considerably, and
many transplanted patients return to work becoming reinte-
grated into the community 3. During regular activity, trans-
planted subjects have shown physical conditioning similar
to that of healthy individuals 4-7. Starling’s axiom, “today’s
physiology will be tomorrow’s medicine” 8, emphasizes the
need for knowledge about post-transplantation cardiovas-
cular adaptations, to serve as the basis for clinical treatment
and rehabilitation. The present article has the aim of discus-
sing the state-of -the-art of this subject.
Aerobic capacity – Aerobic capacity is the total amo-
unt of O2 capable of being metabolized by an organism.
Aerobic potency is the amount of 02 consumed per unit of
time (VO2). Maximal O2 consumption (VO2 max.) or maximal
aerobic potency is the maximum VO2 obtained in an endu-
rance (of progressive loads) test, in which VO2 reaches a
maximal value without additional increase due to an additio-
nal work load. In tests in which the patient does not reach
maximum oxygen consumption, as frequently occurs in car-
diopathy patients and transplanted subjects, peak VO2 is
defined as the highest value of VO2 obtained. Following
cardiac transplantation, patients progress with a reduction
of peak VO2 9-15 of 30-50% 16-22. In our study 6,7, deficits were
32.4% and 25.7% at peak exercise and at the anaerobic
threshold, respectively. Marzo et al 18 found a 35% reduction
in the absolute values of the anaerobic threshold. Degré et
al 23 reported an early and intense accumulation of lactate
during exercise, attributed to increased production in active
tissues and reduced clearance secondary to decreased blo-
od flow in the liver and other inactive tissues. In our study 7,
VO2 in light to moderate submaximal exercise (40 watt load)
below the anaerobic threshold was 12.34 and 12.38ml/kg/
min, in transplanted and healthy  subjects, respectively, wi-
thout significant differences between these groups. Meyer
et al 24, working with a load of 50 watts, reported a VO2 of
0.96 ±0.1 and 0.95±0.08 L/min-1 in  transplanted and control
subjects, respectively.
The reduction of peak VO2 is due to multiple factors,
both central and peripheral. Chronotropic incompetence and
alteration in diastolic function are central factors 21,22,25,26. At
the peripheral level, reduction of peripheral oxygen extraction
occurs 17,21,22,27-29. An exaggerated neuroendocrine respon-
se 19 and reduced capacity of pulmonary diffusion 20,30  also
seem to be involved in decreased tolerance to exercise.
Heart Rate – Heart rate values at rest have been obser-
ved to be higher in transplanted compared with healthy in-
dividuals due to the absence of parasympathetic innerva-
tion and corresponding to the intrinsic frequency of the
sinus node 17,23,31-35. The resting heart rate of transplanted
subjects is 14 to 15 bpm above that of their controls paired
by sex and age 36, and 0 to 26 bpm above controls paired by
sex, age, weight and height 6,7. At the beginning of exercise,
the heart rate rises slowly with a pattern of a depressed cur-
ve relative to that in healthy individuals; frequency accele-
ration is restricted to about one third of that of healthy indi-
viduals 37. It has been reported that this pattern persists for
10 years following transplantation 38. Due to posttransplan-
tation denervation, heart rate is controlled by the humoral
route dependent of the levels of catecholamines released
from the suprarenal gland 9,10. Nevertheless, submaximal
heart rate remains significantly higher in transplanted pati-
ents relative to controls up to levels of 50% of maximal
exercise (fig.1) 39. Such higher levels during submaximal
exercise could reflect increased plasma levels of catechola-
mines, increased density of beta-receptors 40, as well as an in-
trinsic positive chronotropic effect at the pacemaker induced
by venous return 41-43. At peak exercise, the heart rate in
transplanted individuals is 20 to 25% lower than that in heal-
thy controls. This chronotropic deficiency is attributed to
the absence of sympathetic innervation of the sinus node 35.
Persistence of chronotropic incompetence has been obser-
ved 2 to 6 years following cardiac transplantation 22. Later
transplanted patients have better chronotropic responses
than recent ones 44. The improved chronotropic response
during exercise of some patients six months following car-
diac transplantation suggests sympathetic efferent
reinnervation 44. Evidence of late reinnervation in some
transplanted subjects has been demonstrated immunoche-
mically 45. Also, the reappearance of the circadian rhythm of
heart rate in the late cardiac posttransplant follow-up seems
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to reinforce the hypothesis of partial reinnervation in some
transplanted patients 46-48. In the early phase of cardiac pos-
transplantation, cardiac frequency keeps increasing during
the first two minutes of the phase of recovery from exercise,
despite the immediate decrease of circulating catecholami-
nes 23,34 . This delayed deceleration is possibly due to an in-
creased sensitivity of the denervated heart to catecholami-
nes 49 (fig.2). Individuals examined from one to ten years
after transplantation had an immediately decreased heart
rate in the first minute of recovery 23. Kavanagh and Yacoub
reported a reduction in resting heart rate and increased peak
cardiac frequency after two years of physical training. Ho-
wever, resting heart rate  remained higher and peak heart rate
lower when compared to with that in controls. The mecha-
nism responsible for the adaptation of heart rate following
conditioning has not been clarified 49.
Ventricular function – Reduction in systolic volume
during rest and exercise has been reported in transplanted
compared with healthy individuals. Kao et al 22 submitted
transplanted patients to an invasive exercise  test in associ-
ated with oxygen consumption and radioisotope effort ven-
triculography, obtaining direct measurements of the ejection
fraction and ventricular volume. They reported lower
systolic volume in transplanted individuals during rest in
the orthostatic position, submaximal and maximal exercise,
and related this finding to reduced final diastolic volume
secondary to the alteration of diastolic function 21. They
demonstrated that the relationship between pulmonary
capillary pressure and the index of final diastolic volume
(PCP/IVDf) had higher values in transplanted subjects du-
ring rest and during exercise, indicating decreased ventri-
cular complacency 21. Martin et al 26 found similar results in
supine, and orthostatic resting, and at 20% maxímal oxygen
consumption in transplanted subjectes. The pathogenesis
of diastolic dysfunction has not been clarified. Preservation
techniques, length of time of graft ischemia, occurrence of
rejection, systemic arterial hypertension, arterial coronary
disease and the use of cyclosporine have been suggested
as etiological factors 21,26.
During exercise, increased systolic volume, seconda-
ry to the Frank-Starling mechanism and elevations in heart
rate and contractility, secondary to the release of catechola-
mines by the adrenal glands, occur sequentially in trans-
planted patients; the Frank-Starling mechanism is apparent
in the initial phase. In the healthy heart these events occur
simultaneously 50. Despite the chronotropic incompetence
at peak exercise, transplanted subjects make less use of the
Frank-Starling mechanism to increase systolic volume than
do healthy individuals, due to diastolic dysfunction 21.
Follow-up evaluation of these patients did not show impro-
vement of diastolic function 22.
The evaluation of systolic function via ejection
fraction has shown conflicting results. The ejection fraction
of transplanted patients has values similar to those in
healthy individuals during rest and exercise in the orthosta-
tic position 8.5±3.9 months following transplantation 21.
Follow-up evaluation of these patients (2-6 years following
transplantation) showed ejection fraction values sig-
nificantly higher during rest, and similar to normal values
during exercise 22 . Pflufelder et al 51 analyzed ejection
fraction 11 months following transplantation and found
values similar to those in healthy patients, both at rest and
during supine exercise. Tischler et al 52 in a serial evaluation
of ventricular function, found normal ejection fraction
values after one month and after one and four years
following transplantation.
During the first year following transplantation, the
cardiac index reaches significantly lower values in trans-
planted patients at peak exercise, mainly because of a chro-
notropic deficit; in submaximal exercise, this occurs at the
cost of systolic volume 17,21. Two to six years following
transplantation, cardiac index values remain significantly
below normal in such patients 22.
Peripheral oxygen extraction – Peripheral factors play
a relevant role in functional limitation after cardiac trans-
plantation. Bussières et al 53 demonstrated an inverse corre-
lation (p<0.001) between posttransplantation oxygen arte-
riovenous difference (D(a-v) O2) and functional aerobic
Fig. 1 – Variation in heart rate during an exercise test of a 44- year-old male patient
five months following cardiac transplantation due to dilated myocardiopathy. Ctr:
healthy control; Tx; transplanted patient; bpm: beats per min 6.
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Fig. 2 – Pulmonary ventilation during an exercise test in a 38-year-old male patient,
47 months following cardiac transplantation due to dilated myocardiopathy. Ctr:
healthy control; Tx; transplanted patient; VE BTPS- pulmonary ventilation at body
temperature and pressure and under saturation with steam 6.
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deficit (FAI: max.pred.VO2 - peak VO2/max.pred.VO2 x 100),
(r= - 0.66). Savin et al 54 reported a D(a-v)O2 significantly
lower than that of healthy controls at peak exercise. At sub-
maximal exercise levels, a tendency towards higher values of
D(a-v)O2 was found and attributed to a compensatory mecha-
nism in view of the reduction of cardiac output. Kao et al 21
reported D(a-v)O2 values significantly reduced at peak
exercise but similar to control values at rest or submaximal
exercise. Mettauer et al 55 described similar results. The na-
ture of these abnormalities has not been clarified. Irre-
versible alterations due to congestive cardiac insufficiency,
physical deconditioning and prolonged corticoid treatment
may possibly be interfering with these results 56-60.
Vascular resistance – Transplanted patients pro-
gress with a 45 to 92% incidence of arterial hypertension (In-
ternational Registry of Cardiac Transplantation) 61. Borto-
lotto et al 62 observed arterial hypertension in 58.5% of
patients 30 days following surgery,  increasing to 93% after
one year. Despite high blood pressure levels during rest, the
patients’ mean arterial pressure reached values significan-
tly lower than those of healthy controls at peak exercise 21.
In our study, we found significantly higher levels of diasto-
lic arterial pressure at rest and at peak exercise in transplan-
ted subjects relative to that in controls,and no differences
of systolic arterial pressure between groups 6,7. The etiology
of this complication seems to be multifactorial, having as a
common final route the elevation of systemic vascular resis-
tance 63-67. The reason for the attenuated pressure response
at peak exercise has not been clarified 18.
In view of the high incidence of posttransplantation
arterial hypertension, comparative studies of cardiac trans-
plants should include subgroups of apparently healthy and
hypertensive patients. The majority of studies relating to
physiological adaptation of transplanted patients to exerci-
se rely on controls of apparently healthy individuals.
In transplanted subjects, levels of systemic vascular
resistance relative to apparently healthy controls are persis-
tently elevated both at rest and at exercise; however, resting
values undergo marked reduction during exercise, a beha-
vior similar to that of healthy individuals 21,26. Bocchi et al 68
noted a fall in systemic vascular resistance during exercise
in the supine position. Raised systemic vascular resistance
could be attributed to the persistence of a pre-transplanta-
tion abnormality, secondary to congestive cardiac insuffi-
ciency (physical deconditioning, deficient mechanisms of
peripheral vasodilatation due to Na+ and H20 retention) and
special posttransplantation conditions (physical decondi-
tioning, use of cyclosporine and neuroendocrine abnorma-
lities) 21.
Following transplantation, mean pulmonary arterial
pressure is significantly higher at rest and during exercise.
Similarly to that in healthy controls, values rise during the ef-
fort test 21,26. Pulmonary vascular resistance is significantly
elevated in transplanted patients at rest and during exercise
and decreases during effort in the same manner as in healthy
individuals. These findings have been associated with the
irreversibility of vascular pulmonary alterations due to
chronically elevated pressure in the pulmonary artery 21.26.
Pulmonary ventilation - Several studies have pointed
to the excessive ventilation work of the transplanted patient,
characterized by higher values of the ventilatory equivalents
for 02 and CO2 at submaximal exercise 18,19,23. Pulmonary
ventilation at peak exercise is significantly reduced in trans-
planted subjects relative to that in healthy controls 6,7,11,18,19,26
(fig.3). However, when analyzing values of pulmonary ven-
tilation, ventilatory equivalent for oxygen, ventilatory
equivalent for carbon dioxide at the anaerobic threshold
and at the 40W potency, no significant differences between
healthy and transplanted patients are apparent 7. The me-
chanism responsible for the excessive ventilation response
in transplanted individuals has not been clarified. Pope et al
and Savin et al attributed this response to the attenuated
cardiac output curve during exercise secondary to cardiac
denervation with an altered ventilation/perfusion ratio and
an increased physiological dead space 9,54. Marzo et al 18 de-
monstrated that in transplanted patients, the ventilatory
equivalent for carbon dioxide at rest was not significantly
different in relation to that in controls. In this situation car-
diac output was similar to the normal. Another explanation
for the excessive ventilatory response could be muscular
respiratory dysfunction consequent to hypoperfusion and
muscular fatigue 67,70. Kavanagh et al 71 reported significant
improvement in the respiratory response during exercise
following physical training.
Neuroendocrine response – An exaggerated neuro-
endocrine response in transplanted vs control subjects
who performed the same relative levels of exercise has been
reported. Braith et al 19 found neuroendocrine hyperactivity
at rest characterized by significantly higher values of plas-
ma renin and atrial natriuretic peptide. At 70 and 100% peak
VO2, plasma renin activity and estimates of atrial natriuretic
peptide, vasopressin and norepinephrine were significantly
elevated in the transplanted group 19. The neuroendocrine
profile of the transplanted patients could be attributed to the
Fig. 3  – Variation in heart rate during an exercise test of a 30-year-old female patient
16 months following cardiac transplantation due to dilated myocardiopathy. The
exercise peak is indicated by *; bpm: beats per min.
 WORK RATE
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use of cyclosporine 72,73 and hypertensive medication 74, ske-
letal muscle deconditioning 28,75 and cardiac denervation 19.
Cardiac denervation causes loss of the afferent stimulation
of atrial stretch receptors due to disconnection of the heart
from the brain, with consequent reflex inhibition of neuro-
hormones 19. Chronic neuroendocrine hyperactivity has
been associated with the incidence and seriousness of arte-
rial hypertension following cardiac transplantation 19.
Exercise test – Relative to cinecoronariography, the
conventional exercise test shows poor postcardiac trans-
plantation performance in the detection of coronary artery
disease. Sensitivity and positive prediction values were
respectively 21% and 21% (Smart et al 76) and 0% and 0%
(Ehrman et al 77). The detection and evaluation of the se-
riousness of coronary artery disease by myocardial scinti-
lography has been considered class IIB following cardiac
transplantation due to reduced sensitivity and specificity 78.
Ehrman et al 77 attribute the low sensitivity of the exercise
test for the detection of myocardial ischemia to the low car-
diac frequency reached at peak exercise and to the high pre-
valence of complete right branch blockade. Rodney and
Johnson 79 reported the diffuse nature of coronary artery
disease at grafting as the most probable cause of the low
sensitivity of studies of myocardial perfusion.
The exercise test is used in the prescription of exercise
in supervised rehabilitation programs. Cardiac frequency
and arterial pressure responses during effort of transplan-
ted persons are often modest, and other parameters like per-
ceived effort are better for the estimation of the degree of the
exercise. Exercise test protocols must have increments of
lower intensity to give the denervated heart time to respond
to circulatory catecholamines 80. Steady state protocols are
more appropriate because they permit better hormonal and
metabolic adaptation. The VO2 peak is not altered with this
type of protocol 81. Modified forms of the Bruce or Naugh-
ton 49 protocols attaining peak effort in 8-10 min by 1 to 2
MET increments have been used. In the cycloergometer,
increments of 50 or 100 Kpm/min at each minute have been
used 49. We have used increasing load protocols with incre-
ments of 5 watts/minute after an initial stage of 3 min at 25
W, maintaining an average of 50 rotations per min 6,7. The
electrocardiogram is continuously monitored, and the arte-
rial pressure is measured every two min, at the peak of the
exercise and during recovery. Measurements of VE, VO2,
VCO2, RER, PEO2 and PECO2 are made in expired air at each
respiration. Borg’s scale of perceived effort is used at every
stage 49. Special attention should be paid to symptoms of
dyspnea, dizziness, weakness and electrocardiographic
signs, in view of the incapacity of transplanted patients to
manifest angina pectoris.
Cardiac rehabilitation – Long periods of periopera-
tion inactivity, lack of motivation, anxiety, depression, inse-
curity, corticoid-induced skeletal muscle atrophy, recur-
rence of rejection, and reduction in cardiorespiratory per-
formance of the transplanted patient justify the prescription
of physical exercise. A number of physical conditioning
programs have been described 72,82-88. In 1983, Squires et al 82
started a two-month supervised program six weeks follo-
wing cardiac transplantation in two patients. The training
was performed on a treadmill and bicycle three times per
week for 30min using Borg’s scale of perceived effort
between 12 and 13. Kavanagh et al 71 effected a program of
walking and light running five times per week with sessions
of 45 min at 60-70% maximal VO2 and 14 on Borg’s scale. The
training lasted 16±7 months. Ferraz and Arakaki 87 establi-
shed a supervised rehabilitation program with calisthenics
on a stationary bicycle, short walks or runs and recreational
games like adapted volleyball three times a week with
sessions lasting 45 min at the 80% of anaerobic threshold
and Borg’s scale between 13 and 15. The program lasted on
average 14 months. Romano et al 86 trained transplanted
subjects for 6 to 10 months and compared them with a group
of untrained subjects. In the trained group, VO2 was raised
by 85% (vs. 45% in the untrained group). In general,
transplanted subjects should exercise three to five times a
week at between 50 and 75% VO2 and Borg’s scale between
13 and 15. Innumerable benefits of posttransplantation
physical conditioning have been reported: reduced heart
rate and arterial pressure during rest, decreased heart rate,
arterial pressure, ventilartory equivalent for oxygen,
ventilatory equivalent for carbon dioxide in submaximal
exercise; increased heart rate, systolic arterial pressure,
VO2, pulmonary ventilation, and reduction in arterial diasto-
lic pressure at peak exercise; increased aerobic threshold,
retardation of lactate elevation during exercise,  reduction in
effort perception by the Borg scale 72,82-87.
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